Credit: Getty Images. Evidence suggests that patent ductus arteriosus comprises anywhere from 5% to 10% of all congenital heart disease. Although the majority of congenital heart diseases (CHD) are ...
“This position statement represents a collective effort between neonatology, anesthesia, and interventional cardiology to provide comprehensive guidance on tcPDA device occlusion that can be adapted ...
After birth, the pulmonary arterioles dilate and the right heart pressures drop. The left heart pressures increase as the low resistance placenta is replaced by the high-resistance systemic ...
MONDAY, Dec. 15, 2025 (HealthDay News) — Doing nothing at all to manage a common fetal heart defect might improve the ...
Active treatment of hemodynamically significant patent ductus arteriosus (PDA) in preterm infants within the first 2 weeks of life was associated with worse outcomes than expectant management.
Early treatment with ibuprofen for a large patent ductus arteriosus did not result in a lower risk of death or moderate or severe bronchopulmonary dysplasia than placebo at 36 weeks of postmenstrual ...
Hosted on MSN
New guidance released to improve safety and outcomes of patent ductus arteriosus closure in premature infants
The Society for Cardiovascular Angiography & Interventions (SCAI) has published a new position statement that provides best-practice guidance for the treatment of patent ductus arteriosus (PDA) using ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback